249 related articles for article (PubMed ID: 1287032)
21. Recombinant antibodies in cancer therapy.
Nayeem MS; Khan RH
Curr Protein Pept Sci; 2006 Apr; 7(2):165-70. PubMed ID: 16611141
[TBL] [Abstract][Full Text] [Related]
22. Prospects for B-cell-targeted therapy in autoimmune disease.
Edwards JC; Cambridge G
Rheumatology (Oxford); 2005 Feb; 44(2):151-6. PubMed ID: 15509628
[No Abstract] [Full Text] [Related]
23. Engineering therapeutic monoclonal antibodies.
Liu XY; Pop LM; Vitetta ES
Immunol Rev; 2008 Apr; 222():9-27. PubMed ID: 18363992
[TBL] [Abstract][Full Text] [Related]
24. The current status of monoclonal antibodies in the diagnosis and therapy of cancer.
Lowder JN
Curr Probl Cancer; 1986 Oct; 10(10):485-551. PubMed ID: 3536321
[No Abstract] [Full Text] [Related]
25. [Immunotoxins].
Gedikoğlu S
Mikrobiyol Bul; 1990 Jan; 24(1):79-87. PubMed ID: 2283968
[TBL] [Abstract][Full Text] [Related]
26. [1990 Apollinaire Bouchardat Prize. Immunology of insulin-dependent diabetes mellitus: in vitro and in vivo study models in animals].
Boitard C
Journ Annu Diabetol Hotel Dieu; 1990; ():285-99. PubMed ID: 2195212
[No Abstract] [Full Text] [Related]
27. Interleukin-2 receptor-directed immunosuppressive therapies: antibody- or cytokine-based targeting molecules.
Strom TB; Kelley VR; Woodworth TG; Murphy JR
Immunol Rev; 1992 Oct; 129():131-63. PubMed ID: 1464418
[No Abstract] [Full Text] [Related]
28. Therapeutic potential of anti-CD137 (4-1BB) monoclonal antibodies.
Vinay DS; Kwon BS
Expert Opin Ther Targets; 2016; 20(3):361-73. PubMed ID: 26428392
[TBL] [Abstract][Full Text] [Related]
29. Monoclonal antibody-conjugated immunotherapy of cancer.
Imai K; Hareyama M; Makiguchi Y; Matsumoto H; Hinoda Y
Int Rev Immunol; 1997; 14(2-3):213-27. PubMed ID: 9131388
[No Abstract] [Full Text] [Related]
30. Immunological treatment of autoimmune diseases.
Kalden JR; Breedveld FC; Burkhardt H; Burmester GR
Adv Immunol; 1998; 68():333-418. PubMed ID: 9505094
[No Abstract] [Full Text] [Related]
31. Therapeutic intervention with inhibitors of co-stimulatory pathways in autoimmune disease.
Aruffo A; Hollenbaugh D
Curr Opin Immunol; 2001 Dec; 13(6):683-6. PubMed ID: 11677090
[TBL] [Abstract][Full Text] [Related]
32. Treatment of autoimmune diseases with monoclonal antibodies.
Wofsy D
Prog Allergy; 1988; 45():106-20. PubMed ID: 3064092
[No Abstract] [Full Text] [Related]
33. Monoclonal antibody therapy.
O'Mahony D; Bishop MR
Front Biosci; 2006 May; 11():1620-35. PubMed ID: 16368542
[TBL] [Abstract][Full Text] [Related]
34. The use of monoclonal antibody immunoconjugates in cancer therapy.
Pietersz GA; Krauer K; McKenzie IF
Adv Exp Med Biol; 1994; 353():169-79. PubMed ID: 7985535
[No Abstract] [Full Text] [Related]
35. Antibody drug conjugates - Trojan horses in the war on cancer.
Iyer U; Kadambi VJ
J Pharmacol Toxicol Methods; 2011; 64(3):207-12. PubMed ID: 21843648
[TBL] [Abstract][Full Text] [Related]
36. Immunotherapeutic strategies to target prognostic and predictive markers of cancer.
Magee MS; Snook AE; Marszalowicz GP; Waldman SA
Biomark Med; 2013 Feb; 7(1):23-35. PubMed ID: 23387482
[TBL] [Abstract][Full Text] [Related]
37. Monoclonal antibodies and immune therapies for adult precursor B-acute lymphoblastic leukemia.
Sikaria S; Aldoss I; Akhtari M
Immunol Lett; 2016 Apr; 172():113-23. PubMed ID: 26921100
[TBL] [Abstract][Full Text] [Related]
38. Monoclonal antibody therapy of cancer.
DiMaggio JJ; Scheinberg DA; Houghton AN
Cancer Chemother Biol Response Modif; 1990; 11():177-203. PubMed ID: 2223394
[No Abstract] [Full Text] [Related]
39. Strategies in antibody therapy of cancer.
Wawrzynczak EJ; Davies AJ
Clin Exp Immunol; 1990 Nov; 82(2):189-93. PubMed ID: 2242603
[No Abstract] [Full Text] [Related]
40. The emerging therapeutic role of antibody mixtures.
Robak T
Expert Opin Biol Ther; 2013 Jul; 13(7):953-8. PubMed ID: 23646883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
